Article

Discordant Obesity Severity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model

2026-03-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> BMI alone does not capture obesity-related health heterogeneity. The Edmonton Obesity Staging System (EOSS) grades obesity severity based on comorbidities and functional impairment, whereas the Lancet Commission Diagnostic Model for Obesity (DMO) distinguishes preclinical from clinical obesity based on organ dysfunction. We assessed whether both frameworks identify overlappin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36e8f223-6df1-5e2b-809a-3ba48f81eb55
DOI: 10.64898/2026.03.16.26348463

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discordant Obesity Severity Classification Between the Edmonton Obesity Staging System and the Lancet Commission ModelDOI 10.64898/2026.03.16.26348463Read

Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults.Semantic proximity Read

Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK BiobankSemantic proximity Read

Identifying Four Obesity Axes Through Integrative Multiomics and Imaging AnalysisSemantic proximity Read

Beyond Single Anthropometric Measures: Integrating Waist Circumference and Body Mass Index to Stratify Obesity-Related Health Risk.Semantic proximity Read

Associations Between Metabolic Heterogeneity of Obesity and Chronic Multimorbidity Progression: A Nationwide Prospective Cohort Study.Semantic proximity Read

Obesity prevalence: comparison of traditional and new classification approaches in a Swiss population-based study(2005-2024)Semantic proximity Read

Obesity subtypes, related biomarkers & heterogeneity.Semantic proximity Read

Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients With MASLD: Results From the OBREDI-TR StudySemantic proximity Read

Body composition subphenotypes, cardiometabolic risk and incident outcomes: validation in the population-based NAKO and UK Biobank imaging cohortsSemantic proximity Read

Under New Criteria for Clinical Obesity, is Metabolic Obesity with Normal Body Weight Finally a Legitimate Disease Phenotype?Semantic proximity Read

Quantifying the phenome-wide disease burden of obesity using electronic health records and genomics.Semantic proximity Read

Fate of the metabolically healthy obese-is this term a misnomer? A study from the Clinical Practice Research Datalink.Semantic proximity Read